- Type / Class
- Equity / Common Stock
- Shares outstanding
- 51,778,746
- Total 13F shares
- 56,024,433
- Share change
- +3,243,356
- Total reported value
- $994,904,623
- Put/Call ratio
- 154%
- Price per share
- $17.75
- Number of holders
- 217
- Value change
- +$52,668,097
- Number of buys
- 101
- Number of sells
- 108
Quarterly Holders Quick Answers
What is CUSIP 14167L103?
CUSIP 14167L103 identifies CDNA - CareDx, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14167L103:
Top shareholders of CDNA - CareDx, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
8%
from 13D/G
|
5,085,767
|
$108,886,270 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.4%
|
4,859,732
|
$104,046,862 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.1%
|
2,659,099
|
$56,931,310 | — | 31 Dec 2024 | |
| ARK Investment Management LLC |
13F
13D/G
|
Company |
4.5%
from 13D/G
|
2,409,100
|
$51,578,828 | — | 31 Dec 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
4.3%
|
2,207,299
|
$47,258,272 | — | 31 Dec 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
3.1%
|
1,613,992
|
$34,555,569 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
2.9%
|
1,514,850
|
$32,432,938 | — | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
2.9%
|
1,498,018
|
$32,072,565 | — | 31 Dec 2024 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
2.9%
|
1,498,018
|
$32,012,645 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.8%
|
1,432,198
|
$30,663,359 | — | 31 Dec 2024 | |
| GAGNON SECURITIES LLC |
13F
|
Company |
2.8%
|
1,431,196
|
$30,641,916 | — | 31 Dec 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.7%
|
1,374,412
|
$29,426,161 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.4%
|
1,243,580
|
$26,625,048 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,234,263
|
$26,431,798 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.2%
|
1,149,228
|
$24,604,971 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
939,510
|
$20,114,909 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.7%
|
875,197
|
$18,737,968 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
743,004
|
$15,907,461 | — | 31 Dec 2024 | |
| Divisadero Street Capital Management, LP |
13F
|
Company |
1.4%
|
711,761
|
$15,238,803 | — | 31 Dec 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
688,395
|
$14,738,537 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
621,307
|
$13,302,183 | — | 31 Dec 2024 | |
| Blue Water Life Science Advisors, LP |
13F
|
Company |
1.2%
|
604,000
|
$12,931,640 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
585,254
|
$12,530,297 | — | 31 Dec 2024 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.1%
|
563,914
|
$12,073,399 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
547,270
|
$11,717,050 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.99%
|
511,922
|
$10,960,250 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.99%
|
510,044
|
$10,920,042 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
485,789
|
$10,400,743 | — | 31 Dec 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.94%
|
484,286
|
$10,368,563 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.91%
|
468,836
|
$10,037,779 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.9%
|
465,665
|
$9,969,886 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.87%
|
448,113
|
$9,594,099 | — | 31 Dec 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.85%
|
441,207
|
$9,446,000 | — | 31 Dec 2024 | |
| Alexander L. Johnson |
3/4/5
|
President of Patient and Testing Services |
—
mixed-class rows
|
334,552
mixed-class rows
|
$9,284,746 | — | 20 Aug 2024 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
0.82%
|
423,471
|
$9,066,514 | — | 31 Dec 2024 | |
| Gagnon Advisors, LLC |
13F
|
Company |
0.8%
|
412,875
|
$8,839,654 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.77%
|
398,000
|
$8,521,180 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.73%
|
378,524
|
$8,104,000 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.66%
|
340,910
|
$7,298,883 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.65%
|
338,497
|
$7,244,000 | — | 31 Dec 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.64%
|
333,876
|
$7,148,285 | — | 31 Dec 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.63%
|
327,343
|
$7,008,414 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.6%
|
313,259
|
$6,706,868 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.56%
|
289,457
|
$6,197,275 | — | 31 Dec 2024 | |
| Abraham Ronai |
3/4/5
|
Officer |
—
class O/S missing
|
515,986
|
$6,160,873 | — | 20 Sep 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.54%
|
281,339
|
$6,023,468 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.54%
|
279,309
|
$5,980,006 | — | 31 Dec 2024 | |
| Reginald Seeto |
3/4/5
|
President and Chief Executive Officer, Director |
—
class O/S missing
|
479,164
|
$5,721,218 | — | 02 Oct 2023 | |
| Intrinsic Edge Capital Management LLC |
13F
|
Company |
0.49%
|
255,000
|
$5,459,550 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.45%
|
231,235
|
$4,950,741 | — | 31 Dec 2024 |
Institutional Holders of CareDx, Inc. - Common Stock (CDNA) as of Q1 2025
As of 31 Mar 2025,
CareDx, Inc. - Common Stock (CDNA) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,024,433 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Invesco Ltd., STATE STREET CORP, ARK Investment Management LLC, BAMCO INC /NY/, Ophir Asset Management Pty Ltd, Hood River Capital Management LLC, FRED ALGER MANAGEMENT, LLC, and GAGNON SECURITIES LLC.
This page lists
216
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
209
Q1 2025 holders
217
Holder diff
8
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.